期刊文献+

胰岛素聚β-羟基丁酸酯微球制备工艺的研究 被引量:3

Study on Preparation Technology of Insulin-Poly(β-hydroxybutyrate)Microspheres
下载PDF
导出
摘要 目的:以生物降解材料聚β-羟基丁酸酯(PHB)为载体材料制备胰岛素微球。方法:采用液中干燥法制备,并通过均匀设计法和星点设计法来优化其制备工艺,经差示扫描量热分析(DSC)进行物相验证。结果:微球的DSC图谱中仅有PHB的峰,而胰岛素的特征峰消失。结论:证明形成了胰岛素聚β-羟基丁酸酯微球。 Objective: To prepare insulin microspheres with biodegradable poly ([3-hydroxybutyrate) as the material. Method: The microspheres were prepared by in-liquid drying method and the uniform design and central composite design were used to optimize the preparation technology. The differential scanning calorimetry was used to identify the material phase. Result: In the diagrams of differential scanning calorimetry, the characteristic peak of insulin disappeared and only that of poly(β-hydroxybutyrate) remained. Conclusion: The results showed that the insulin-poly(β-hydroxybutyrate) microspheres were formed.
出处 《中国药师》 CAS 2008年第6期613-617,共5页 China Pharmacist
基金 国家教委博士点基金项目(编号9504113)
关键词 胰岛素 聚Β-羟基丁酸酯 微球 液中干燥法 均匀设计法 星点设计法 Insulin Poly (β-hydroxybutyrate) Microspheres In-liquid drying method Uniform design Central composite design
  • 相关文献

参考文献14

二级参考文献50

  • 1侯春林,盛志坚,卢建熙,曹梅讯,吴清基.几丁质缝合线体内吸收的实验研究[J].第二军医大学学报,1994,15(5):452-453. 被引量:17
  • 2黄根龙.降解塑料研究现状和发展趋势[J].上海化工,1996,21(2):32-36. 被引量:19
  • 3Nonami Toru. Manufacture of Bone Substitute with Porous HAP and TCP. JP 01,293,877,1989-11-27.
  • 4Oxaki Ryuichi,Manufacture of Artificial Tooth Root by Coating Porous Alumina withHAP. JP 02,184,580,1990-7-19,4pp.
  • 5汪忠镐.外科缝合材料的进展—合成缝线[J].国外医学参考资料外科学手册,1977,3:127-127.
  • 6PH Giaig. et al. Surgery Gynnecology & obstertrics. 141.1- 10(1975).
  • 7Assno,M,Fukuzaki,H.J. Controlled Release. 1998,7,69.
  • 8黄玉东.聚合物表而与界而技术[M].北京:化学工业与工程出版社,2003..
  • 9Toshio H.Prong[J].Polym Sci,1994,19:663.
  • 10Rebecca Kuniz M,Mark Saltzman W.TIBTECH,1997,15:361.

共引文献936

同被引文献20

  • 1王鹏,王玉珠,沈建民.均匀设计及其在药学中的应用[J].沈阳药学院学报,1989,6(4):297-305. 被引量:74
  • 2席延卫,王娟,翟光喜.胰岛素口服制剂的研究现状[J].中国生化药物杂志,2006,27(1):58-60. 被引量:6
  • 3张金玲.胰岛素鼻腔给药制剂的试验研究[J].天津药学,2006,18(4):6-8. 被引量:6
  • 4Yamada S, Matsuoka Y, Kato Y, et al. A Review on Barnidipine:A Novel Calcium Antagonist [J]. Cardiovascular Drug Reviews, 1995,15 (4):273 -290.
  • 5Gershanik T,Benita S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs[J]. Eur J Pharm Bio,2000,50(2) :1791-1798.
  • 6Montgomery DC. Response surface methodology:Montgomery DC Design and analysis of experiments [ M ]. 2 eds. New York:John Wiley & Sons, 1984.445-474.
  • 7Verma RK, Mishra B, Garg S. Osmotically controlled oral drug delivery [ J ]. Drug Dev lnd Pharm,2000,26( 7 ):695-708.
  • 8Attivi D, Wehle P, Ubrich N, et al. Formulation of insulin-loaded polymeric nanoparticles using response surface methodology [ J]. Drug Dev Ind Pharm ,2005, 31 (2) : 179-189.
  • 9丁立,孙素珍.胰岛素非注射给药的现状综述[J].药学与临床研究,2007,15(4):264-266. 被引量:2
  • 10Singha L,Kumara VRatner BD.Generation of porous microcellular 85/15 poly (dl-lactide-co-glycolide) foams for biomedical applications[J].Biomaterials,2004,25(13):2611.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部